Followers | 170 |
Posts | 8965 |
Boards Moderated | 0 |
Alias Born | 01/24/2011 |
Thursday, October 01, 2015 9:14:07 PM
Ever since the hemp bills were introduced in the U.S. Congress in early 2015, I've stated that HEMP wouldn't be processing hemp in the plant in 2015. Unless Perlowin imports a few stalks during the startup tests, that prediction will be correct.
From January, 2015:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110313040
Even with the change in NC law, HEMP is now committed to processing kenaf through at least the first half of 2016, and if there is hemp available for processing at the end of 2016, then whether or not he converts the equipment to handle hemp will depend upon how well things are going with the kenaf.
I don't care if HEMP is a leader in industrial hemp, because I look at the financials of the company, and the way I see it, unless the kenaf market really takes off, the combination of loans from Perlowin and share conversion will result in a much higher OS than HEMP has now, and normal EPS rules will apply, because we're talking about and agricultural commodity business.
Therefore, I'll be looking at HEMP's market cap versus the share count and EPS.
Right now, HEMP has a market cap of about $17M on 320M shares. Some think that's too low, but I think it's about right, considering we're looking at losses 3Q/15 and 4Q/15. But what happens if we find out that by the end of September, the OS had risen to 600M shares due to conversion of Preferred K shares and/or the payment of shares for services?
In that case, we're looking at a company that's valued at $31M yet still has the same losses in 3Q/15. IMO, that would make the company overvalued.
So Perlowin's in a race against time, whether or not he's able to process hemp in 2016.
"Soylent Green is people!!!"
Detective Robert Thorn: Telling uncomfortable truths since 2022
DRT is Charleton Heston's character in the 1973 movie, Soylent Green, set in the year 2022, and is not my real name
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM